CD8A and melanoma: Besides, it has previously been shown that immunization of tumor-bearing mice with mutated melanoma-derived self-antigens can elicit efficient cross-reactive CD8+ T cell responses against multiple non-mutated epitopes of the tumor protein and against the melanoma cells (109).